Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-01-04 @ 10:16 AM
Study NCT ID:
NCT04982068
Status:
UNKNOWN
Last Update Posted:
2023-04-19
First Post:
2021-07-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
Sponsor:
Shanghai Zerun Biotechnology Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
202-COV-1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |